tiprankstipranks
Cantargia AB (SE:CANTA)
:CANTA
Sweden Market
CANTA
Cantargia AB
RESEARCH TOOLSreports

Cantargia AB (CANTA) Stock News & Sentiment

3 Followers
Cantargia Showcases Promising Nadunolimab Data in Hard-to-Treat Colorectal Cancer
Premium
Company Announcements
Cantargia Showcases Promising Nadunolimab Data in Hard-to-Treat Colorectal Cancer
24d ago
Cantargia to Court Investors at Van Lanschot Kempen Life Sciences Conference
Premium
Company Announcements
Cantargia to Court Investors at Van Lanschot Kempen Life Sciences Conference
1M ago
Cantargia to Highlight Antibody Platform at TD Cowen Healthcare Conference
Premium
Company Announcements
Cantargia to Highlight Antibody Platform at TD Cowen Healthcare Conference
2M ago
Cantargia: Solid Cash Runway and Expanding Nadunolimab Pipeline Support Buy Rating and Long-Term Upside
Premium
Ratings
Cantargia: Solid Cash Runway and Expanding Nadunolimab Pipeline Support Buy Rating and Long-Term Upside
2M ago
Cantargia Highlights Pipeline Progress in 2025 Year-End Report
Premium
Company Announcements
Cantargia Highlights Pipeline Progress in 2025 Year-End Report
2M ago
Cantargia Sets Date for 2025 Annual Results and Investor Presentation
Premium
Company Announcements
Cantargia Sets Date for 2025 Annual Results and Investor Presentation
2M ago
Cantargia to Engage Investors at Leerink Global Healthcare Conference
Premium
Company Announcements
Cantargia to Engage Investors at Leerink Global Healthcare Conference
2M ago
More SE:CANTA News >

CANTA News on the Web

Cantargia: Solid Cash Runway and Expanding Nadunolimab Pipeline Support Buy Rating and Long-Term Upside
TipRanks News
Bullish
Cantargia Sets Date for 2025 Annual Results and Investor Presentation
TipRanks News
Bullish
Cantargia to Engage Investors at Leerink Global Healthcare Conference
TipRanks News
Bullish
Expanding Nadunolimab’s Oncology Footprint: Low-Cost MSS-CRC Study De-Risks Pivotal Pancreatic Program and Supports Buy Rating on Cantargia AB
TipRanks News
Bullish
Cantargia Begins US Trial of Nadunolimab Combo in Hard-to-Treat Colorectal Cancer
TipRanks News
Bullish
Cantargia AB’s Promising Interim Report for Early 2025
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SE:CANTA’s Media Buzz Sentiment?
Currently, no data Available
What is SE:CANTA’s weekly average amount of articles?
Currently, no data Available
What is SE:CANTA’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
NBIXNeurocrine
STAAStaar Surgical
AORTArtivion
OWLTOwlet
HUMHumana
Showing the stocks with the most bullish news sentiment over the past week